Skip to Content
Is your RA under control? Take an assessment and find out

Etidronate Pregnancy and Breastfeeding Warnings

Etidronate is also known as: Didronel, Didronel IV

Etidronate Pregnancy Warnings

Bisphosphonates are incorporated into the bone matrix, from where they are gradually released over periods of weeks to years. Therefore, there is a theoretical risk of fetal harm if a woman becomes pregnant after completing a course of bisphosphonate therapy. Animal studies using oral doses up to 100 mg/kg failed to reveal evidence of teratogenicity. However, at doses of 300 mg/day, skeletal malformations were noted in the offspring of rats. Skeletal effects are thought to be due to the pharmacological effect of the dug on bone. Doses 25 to 200 times the recommended human dose resulted in maternal toxicity and decrease in number of live births. There are no controlled animal pregnancy data with IV etidronate.

Etidronate has been assigned to pregnancy category C by the FDA. Etidronate has been shown to cause skeletal abnormalities in rats when given at oral dose levels of 300 mg/kg (15 to 60 times the human dose). Other effects on the offspring (including decreased live births) are at dosages that cause significant toxicity in the parent generation and are 25 to 200 times the human dose. There are no controlled data in human pregnancy. Etidronate is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Etidronate Breastfeeding Warnings

There are no data on the excretion of etidronate into human milk. The manufacturer recommends that caution be used when administering etidronate to nursing women.

See references

References for pregnancy information

  1. "Product Information. Didronel I.V. Infusion (etidronate)." MGI Pharma Inc, Minnetonka, MN.
  2. "Product Information. Didronel Tablets (etidronate)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.

References for breastfeeding information

  1. "Product Information. Didronel Tablets (etidronate)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.
  2. "Product Information. Didronel I.V. Infusion (etidronate)." MGI Pharma Inc, Minnetonka, MN.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.